Screener
Globus Medical GMED Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $7.07M+921% | $5.43M+223% | $7.12M+267% | $9K-67.9% | $693K+2,467% | ||
| $151.57M-25.3% | $124.3M+64.7% | $140.59M+430% | $118.97M+130% | $202.85M+539% | ||
| $1.10-26.2% | $0.90+66.7% | $1.02+437% | $0.88+132% | $1.49+548% | ||
| $251.93M+71.7% | $220.24M+35.4% | $238.35M+86.4% | $208.91M+81.6% | $146.74M+29.6% | ||
| $182.43M+140% | $150.39M+55.0% | $169.34M+181% | $137.36M+186% | $76.11M+53.4% |
FAQ
- What is Globus Medical's revenue?
- Globus Medical (GMED) generated $3.1B in revenue over the trailing twelve months, up 19.7% year over year.
- Is Globus Medical profitable?
- Globus Medical reported $535.4M in net income over the trailing twelve months, a 17.0% net margin.
- What are Globus Medical's profit margins?
- Gross margin is 68.5% and operating margin is 20.3%, with a 17.0% net margin.
- What is Globus Medical's earnings per share?
- Globus Medical's diluted EPS over the trailing twelve months is $3.90.
- Where does Globus Medical's income statement data come from?
- Every line is extracted from Globus Medical's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
